These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 32290239

  • 1. Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy.
    Weng CC, Hsiao IT, Yang QF, Yao CH, Tai CY, Wu MF, Yen TC, Jang MK, Lin KJ.
    Molecules; 2020 Apr 10; 25(7):. PubMed ID: 32290239
    [Abstract] [Full Text] [Related]

  • 2. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
    Kimura T, Ono M, Seki C, Sampei K, Shimojo M, Kawamura K, Zhang MR, Sahara N, Takado Y, Higuchi M.
    Eur J Nucl Med Mol Imaging; 2022 Nov 10; 49(13):4298-4311. PubMed ID: 35798978
    [Abstract] [Full Text] [Related]

  • 3. In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study.
    Kong Y, Cao L, Wang J, Zhuang J, Xie F, Zuo C, Huang Q, Shi K, Rominger A, Li M, Wu P, Guan Y, Ni R.
    J Neurol Sci; 2024 Jul 15; 462():123079. PubMed ID: 38878650
    [Abstract] [Full Text] [Related]

  • 4. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
    Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M.
    J Nucl Med; 2018 Jun 15; 59(6):960-966. PubMed ID: 29419480
    [Abstract] [Full Text] [Related]

  • 5. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.
    Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, Van Leuven F, Okamura N, Herms J, Rominger A.
    J Nucl Med; 2016 May 15; 57(5):792-8. PubMed ID: 26912432
    [Abstract] [Full Text] [Related]

  • 6. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M.
    Brain; 2017 Mar 01; 140(3):764-780. PubMed ID: 28087578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.
    J Nucl Med; 2016 Apr 01; 57(4):574-81. PubMed ID: 26795290
    [Abstract] [Full Text] [Related]

  • 12. Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [18 F]PM-PBB3 for clinical applications.
    Kawamura K, Hashimoto H, Furutsuka K, Ohkubo T, Fujishiro T, Togashi T, Arashi D, Sakai T, Muto M, Ogawa M, Kurihara Y, Nengaki N, Takei M, Nemoto K, Higuchi M, Zhang MR.
    J Labelled Comp Radiopharm; 2021 Mar 01; 64(3):109-119. PubMed ID: 33067819
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
    Endepols H, Anglada-Huguet M, Mandelkow E, Schmidt Y, Krapf P, Zlatopolskiy BD, Neumaier B, Mandelkow EM, Drzezga A.
    Mol Neurobiol; 2022 Jun 01; 59(6):3402-3413. PubMed ID: 35312967
    [Abstract] [Full Text] [Related]

  • 14. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer's Disease.
    Kong Y, Maschio CA, Shi X, Xie F, Zuo C, Konietzko U, Shi K, Rominger A, Xiao J, Huang Q, Nitsch RM, Guan Y, Ni R.
    Mol Neurobiol; 2024 Oct 01; 61(10):8387-8401. PubMed ID: 38502413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    Kimura Y, Ichise M, Ito H, Shimada H, Ikoma Y, Seki C, Takano H, Kitamura S, Shinotoh H, Kawamura K, Zhang MR, Sahara N, Suhara T, Higuchi M.
    J Nucl Med; 2015 Sep 01; 56(9):1359-65. PubMed ID: 26182966
    [Abstract] [Full Text] [Related]

  • 19. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L, Egebjerg J, Barkholt P, Volbracht C.
    Brain Res; 2017 Jun 15; 1665():22-35. PubMed ID: 28411086
    [Abstract] [Full Text] [Related]

  • 20. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ.
    PLoS One; 2016 Jun 15; 11(6):e0158460. PubMed ID: 27355840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.